Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1740studies shown
Showing 1,645-1,656 of 1,740
Other study type icon
CompletedNCT01014195

Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors

This summary needs review. Please check the official study record and contact the research team for details.

In Memphis
Why is this study shown?

This study is directly about ADHD.

ADHDObservationalA study where researchers collect information without assigning a treatment.Over 8 Years
Countries
United States
Sponsor
St. Jude Children's Research Hospital
Condition
ADHD
Drug study icon
CompletedNCT01114737

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including La Jolla
Why is this study shown?

This study is directly about ADHD.

ADHDDrugA study involving a medication or substance.From 8 Years to 65 Years
Countries
United States, Canada
Sponsor
BioMarin Pharmaceutical
Condition
ADHD
Drug study icon
CompletedNCT00634439

Safety Study of Atomoxetine and Cerebrovascular Outcomes

This summary needs review. Please check the official study record and contact the research team for details.

In Indianapolis
Why is this study shown?

This study is directly about ADHD.

ADHDDrugOver 18 Years
Countries
United States
Sponsor
Eli Lilly and Company
Condition
ADHD
Other study type icon
CompletedNCT00614198

ScanBrit Dietary Intervention in Autism

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about ADHD.

ADHDOtherFrom 4 Years to 11 Years
Countries
Sponsor
Center for Autisme, Denmark
Condition
ADHD
Behavioral study icon
CompletedNCT04091633

School Health Implementation Network: Eastern Mediterranean

This summary needs review. Please check the official study record and contact the research team for details.

In Islamabad
Why is this study shown?

This study is directly about ADHD.

ADHD, Depression, ...BehavioralFrom 8 Years to 13 Years
Countries
Pakistan
Sponsor
Human Development Research Foundation, Pakistan
Condition
ADHD, Depression, ...
Other study type icon
CompletedNCT06878690

Sleep Disorders in Specific Learning Disabilities

This summary needs review. Please check the official study record and contact the research team for details.

In Bron
Why is this study shown?

This study is directly about ADHD.

ADHDObservationalOver 4 Years
Countries
France
Sponsor
Hospices Civils de Lyon
Condition
ADHD
Drug study icon
CompletedNCT01183234

SPD544 High Strength Bioequivalence Study

This summary needs review. Please check the official study record and contact the research team for details.

In London
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
Shire
Condition
ADHD
Drug study icon
CompletedNCT03769064

Study for Naltrexone on the Abuse Potential of Methylphenidate

This summary needs review. Please check the official study record and contact the research team for details.

In Overland Park
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
Avekshan LLC
Condition
ADHD
Other study type icon
CompletedNCT00472511

Eyes and Attention Deficit (SEAD)

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about ADHD.

ADHDObservationalFrom 7 Years to 18 Years
Countries
Sponsor
Ohio State University
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.